ANXA1 and non-small cell lung carcinoma: High abundance of ANXA1 was identified in patients with lung cancer while knockdown of ANXA1 can inhibit the proliferation, migration and invasion of NSCLC, especially in A549 cell line (Fang et al., 2016; Liu et al., 2011; Qiu et al., 2008).